Astrana HealthASTH +0.14%87 EV-to-OCF is 16.19 as of Jul. 12, 2026, which is 26% below its 10-year median of 21.89. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $83.00 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Astrana Health ranks worse than 71.64% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Astrana Health's Enterprise Value is $2,688 Mil.
Astrana Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $166 Mil. Therefore, Astrana Health's EV-to-OCF for today is 16.19.
The historical rank and industry rank for Astrana Health's EV-to-OCF or its related term are showing as below:
ASTH'
s EV-to-OCF Range Over the Past 10 Years
Min: -123.24 Med: 21.89 Max: 244.36
Current: 16.19
During the past 13 years, the highest EV-to-OCF of Astrana Health was 244.36. The lowest was -123.24. And the median was 21.89.
ASTH's EV-to-OCF is ranked worse than 71.64% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 8.63
vs ASTH: 16.19
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Astrana Health's PE Ratio (TTM) for today is calculated as:
Astrana Health's share price for today is $46.875.
Astrana Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.610.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Astrana Health EV-to-OCF Related Terms
Astrana Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Astrana Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Astrana Health's EV-to-OCF falls into.
Astrana Health's current Enterprise Value is $2,688 Mil.
Astrana Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $166 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health (ASTH) has a EV-to-OCF of 16.19 as of Jul. 12, 2026. This is 26% below median its historical median of 21.89. According to the industry distribution chart, Astrana Health ranks #490 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 71.6%.
Is Astrana Health's EV-to-OCF too high?
Astrana Health's current EV-to-OCF of 16.19 is 26% below median its 10-year median of 21.89. The Healthcare Providers & Services industry median EV-to-OCF is 8.63. Astrana Health's value of 16.19 is 87.6% above this industry median. Based on the distribution chart, Astrana Health ranks #490 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's EV-to-OCF compare to SGRY and SEM?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #490 out of 684 companies for EV-to-OCF. This places Astrana Health in the lower half of its industry. The industry median EV-to-OCF is 8.63. Astrana Health's value of 16.19 is 87.6% above this benchmark. While the company's 10-year median is 21.89 vs. the industry median of 8.63, Astrana Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.63, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current EV-to-OCF of 16.19 is 87.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current EV-to-OCF is 16.19, which is 26% below median its own 10-year median of 21.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $83.00, compared to a current price of $46.88 — trading 43.5% below its estimated fair value. The current EV-to-OCF is 16.19, which is 26% below median its 10-year median of 21.89 and 87.6% above the Healthcare Providers & Services industry median of 8.63. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Astrana Health (ASTH), the current EV-to-OCF is 16.19 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $46.88 is trading 43.5% below its estimated GF Value™ of $83.00.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
EV-to-OCF: 16.19 (26% below median its 10-year median of 21.89)
GF Value™: $83.00 vs. price of $46.88 (43.5% below fair value)
Industry Position: 87.6% above the Healthcare Providers & Services median (#490 of 684)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
